A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects
An Open, Parallel Design Clinical Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects in Single and Multiple Doses
Sponsor: Henan Genuine Biotech Co., Ltd.
Listed as NCT06991634, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Henan Genuine Biotech Co., Ltd., it has been updated 2 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE1
-
Jun 2025 — Dec 2025 [monthly]
Completed PHASE1
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Henan Genuine Biotech Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .